Fred Alger Management’s Royalty Pharma RPRX Stock Holding History

Fred Alger Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95M	Buy	34,725 +762	+2%	+$39.7K	0.01%	320
2026 Q1	$1.63M	Sell	33,963 -1,846	-5%	-$80.8K	0.01%	333
2025 Q4	$1.38M	Sell	35,809 -40,310	-53%	-$1.54M	0.01%	336
2025 Q3	$2.69M	Sell	76,119 -39,493	-34%	-$1.43M	0.01%	302
2025 Q2	$4.17M	Buy	+115,612	New	+$3.83M	0.02%	253
2021 Q3	–	Sell	-88,810	Closed	-$3.64M	–	551
2021 Q2	$3.64M	Buy	88,810 +60,510	+214%	+$2.57M	0.01%	321
2021 Q1	$1.23M	Sell	28,300 -416	-1%	-$19.7K	﹤0.01%	368
2020 Q4	$1.44M	Buy	28,716 +17,608	+159%	+$747K	﹤0.01%	347
2020 Q3	$467K	Sell	11,108 -5,392	-33%	-$231K	﹤0.01%	380
2020 Q2	$801K	Buy	+16,500	New	+$817K	﹤0.01%	368

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fred Alger Management's RPRX Position: Q2 2026 in Review

Fred Alger Management increased its Royalty Pharma (RPRX) stake by 2.2% in Q2 2026, buying an estimated $39.7K and bringing the position to 34,725 shares worth $1.95M. The position accounts for 0.01% of the portfolio, ranked #320.

Fred Alger Management first reported a position in RPRX in Q2 2020 and has held it in 10 quarters since. The position peaked at $4.17M in Q2 2025. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Fred Alger Management held 34,725 shares of Royalty Pharma worth $1.95M as of Q2 2026.
Fred Alger Management bought 762 Royalty Pharma shares in Q2 2026, an estimated $39.7K.
Royalty Pharma made up 0.01% of Fred Alger Management's portfolio in Q2 2026, its #320 holding.
Fred Alger Management first reported a position in Royalty Pharma in Q2 2020 and has held it in 10 quarters since.
Fred Alger Management's Royalty Pharma position peaked at $4.17M in Q2 2025.
641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.